The FDA gives the green light to the first gene therapy for deafness

""It's the first time in history there's a new drug for hearing loss," says Zheng-Yi Chen, highlighting the significance of the FDA's approval of the gene therapy."

""I think it's an historical event, a landmark, a great development for the whole field," Chen adds, emphasizing the impact of this advancement on hearing loss treatments."

""About two and a half to three months after, we were driving in the car and he was sleeping. And I laughed really loud, and he startled for the first time ever," recalls Sierra Smith, reflecting on her son's response to sound after the therapy."

The FDA has approved a groundbreaking gene therapy aimed at restoring hearing for individuals born with a specific genetic form of deafness. This approval marks a significant milestone in the treatment of hearing loss. The therapy involves infusing a virus carrying the otoferlin gene into the ears of patients, which can potentially enable their brains to process sound. Parents of affected children, like Sierra Smith, have reported promising results, including their children responding to sounds for the first time after treatment.

Read at www.npr.org